Trade BioNTech ^BNTX

Assessing BioNTech (BNTX) Valuation After Prolonged Share Price Weakness And Loss Making Results

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Biontech SE Annual Shareholders Meeting Transcript

BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM

BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center

CDC admits Moderna vaccine poses higher risk of heart inflammation

Berenberg Bank Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00

BioNTech (BNTX) Sees Price Target Adjustment Amid Oncology Pipeline Valuation

Why BioNTech (BNTX) Is Down 5.3% After Authorizing a $1 Billion ADS Buyback and Reaffirming 2026 Guidance

BioNTech: Profit takes precedence over health-and 1,860 employees lose their jobs in Germany - World Socialist Web Site

BioNTech (NASDAQ:BNTX) Stock Rating Upgraded by Wall Street Zen

BioNTech (NASDAQ:BNTX) to Buyback $1.00 billion in Shares

Other news to note for May 7, 2026 | BioWorld

BNTX Stock News: BioNTech Announces Layoffs as Covid-19 Revenue Slides

Wells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Analysts

BioNTech Earnings: Clinical Development on Track, Busy Schedule for the Remainder of the Year | Morningstar

Health Care Up After Earnings - Health Care Roundup | Morningstar

BioNTech Q1 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) Announces Earnings Results - Zolmax

BioNTech to cut up to 1,860 jobs as Covid jab sales drop

BioNTech (NASDAQ:BNTX) Posts Earnings Results, Beats Estimates By $0.26 EPS - Daily Political

BioNTech (BNTX) Is Down 7.5% After Tariff Jitters, Leadership Shifts And Cut Guidance Reset - Has The Bull Case Changed?

BioNTech Faces Tariff Risks And Leadership Shift As Oncology Plans Advance

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next?

CureVac targets Moderna with 10-patent suit over Spikevax

BioNTech (BNTX) Expected to Announce Quarterly Earnings on Tuesday

BioNTech SE Sponsored ADR $BNTX Shares Sold by Flossbach Von Storch SE

BioNTech (BNTX) - Research Analysts' Recent Ratings Updates - Daily Political

BioNTech Stock Forecast | Co-Founder Exit, 2026 Guidance Cut | Capital.com

HC Wainwright Reaffirms "Buy" Rating for BioNTech (NASDAQ:BNTX)

BNTX Reiterates by HC Wainwright & Co. -- Price Target Maintaine

CureVac sues Moderna for patent infringement over COVID-19 vaccines

BioNTech SE (BNTX) PT Slightly Raised as Morgan Stanley Updates Biopharma Coverage Models

Sierk Poetting Sells 50,000 Shares of BioNTech (NASDAQ:BNTX) Stock

Why BioNTech (BNTX) Is Up 9.2% After Strong Phase 2 HER2 ADC Data In Endometrial Cancer

BioNTech (BNTX) Price Target Raised Following Successful T-Pam Data

BioNTech (NASDAQ:BNTX) COO Sierk Poetting Sells 50,000 Shares - Daily Political

BioNTech (BNTX) Is Up 13.4% After Positive HER2 Endometrial Cancer Phase 2 Data Release

BNTX: Leadership Turnover And Weak COVID Outlook Will Pressure Future Expectations

BioNTech (BNTX) Gains Investor Interest Following Promising ASCO Presentation

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Recent Share Price Momentum